AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
Balance sheet
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $5.7B | $5.5B | $5.8B | $6.2B | $6.3B | $7.8B | $5.4B | $4.8B | $3.3B | $5.0B | $6.2B |
| Inventory | $6.6B | $5.3B | $5.4B | $4.7B | $9.0B | $4.0B | $3.2B | $2.9B | $3.0B | $2.3B | $2.1B |
| Current assets | $28.7B | $25.8B | $25.1B | $22.6B | $26.2B | $19.5B | $15.6B | $15.6B | $13.2B | $13.3B | $16.0B |
| Goodwill | $21.2B | $21.0B | $20.0B | $19.8B | $20.0B | $11.8B | $11.7B | $11.7B | $11.8B | $11.7B | $11.8B |
| Intangible assets | $37.8B | $37.2B | $38.1B | $39.3B | $42.5B | $20.9B | $20.8B | $22.0B | $26.2B | $27.6B | $22.6B |
| Total assets | $114.1B | $104.0B | $101.1B | $96.5B | $105.4B | $66.7B | $61.4B | $60.7B | $63.4B | $62.5B | $60.1B |
| Current liabilities | $30.6B | $27.9B | $30.5B | $26.3B | $22.6B | $20.3B | $18.1B | $16.3B | $16.4B | $15.3B | $14.9B |
| Long-term debt | $24.7B | $26.5B | $22.4B | $23.0B | $28.1B | $17.5B | $15.7B | $17.4B | $15.6B | $14.5B | $14.1B |
| Total liabilities | $65.4B | $63.2B | $62.0B | $59.4B | $66.1B | $51.1B | $46.8B | $46.6B | $46.7B | $45.9B | $41.5B |
| Shareholders' equity | $48.7B | $40.8B | $39.1B | $37.0B | $39.3B | $15.6B | $13.1B | $12.5B | $15.0B | $14.9B | $18.5B |
| Current ratio | 0.94 | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 | 0.86 | 0.96 | 0.80 | 0.87 | 1.08 |